169 related articles for article (PubMed ID: 17134675)
21. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
22. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
Prabhu V; Lui H; King J
Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
[TBL] [Abstract][Full Text] [Related]
23. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
24. An alternative pathway for reduced folate biosynthesis in bacteria and halophilic archaea.
Levin I; Giladi M; Altman-Price N; Ortenberg R; Mevarech M
Mol Microbiol; 2004 Dec; 54(5):1307-18. PubMed ID: 15554970
[TBL] [Abstract][Full Text] [Related]
25. Hybrid-drug design targeting Pseudomonas aeruginosa dihydropteroate synthase and dihydrofolate reductase.
Jayaraman P; Sakharkar KR; Daniel LC; Siddiqi MI; Dhillon SK; Sakharkar MK
Front Biosci (Elite Ed); 2013 Jun; 5(3):864-82. PubMed ID: 23747902
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis.
Gengenbacher M; Xu T; Niyomrattanakit P; Spraggon G; Dick T
FEMS Microbiol Lett; 2008 Oct; 287(1):128-35. PubMed ID: 18680522
[TBL] [Abstract][Full Text] [Related]
27. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
[TBL] [Abstract][Full Text] [Related]
28. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
29. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Merali S; Zhang Y; Sloan D; Meshnick S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
[TBL] [Abstract][Full Text] [Related]
32. New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.
Suling WJ; Seitz LE; Reynolds RC; Barrow WW
Antimicrob Agents Chemother; 2005 Nov; 49(11):4801-3. PubMed ID: 16251337
[TBL] [Abstract][Full Text] [Related]
33. Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100.
Talarico TL; Dev IK; Dallas WS; Ferone R; Ray PH
J Bacteriol; 1991 Nov; 173(21):7029-32. PubMed ID: 1657875
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
35. Structural enzymology and inhibition of the bi-functional folate pathway enzyme HPPK-DHPS from the biowarfare agent Francisella tularensis.
Shaw GX; Li Y; Shi G; Wu Y; Cherry S; Needle D; Zhang D; Tropea JE; Waugh DS; Yan H; Ji X
FEBS J; 2014 Sep; 281(18):4123-37. PubMed ID: 24975935
[TBL] [Abstract][Full Text] [Related]
36. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
37. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
38. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
[TBL] [Abstract][Full Text] [Related]
39. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
40. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]